Retrograde chronic total occlusion percutaneous coronary intervention via ipsilateral collaterals.

Autor: Al-Ogaili A; Minneapolis Heart Institute, Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA., Alexandrou M; Minneapolis Heart Institute, Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA., Rempakos A; Minneapolis Heart Institute, Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA., Mutlu D; Minneapolis Heart Institute, Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA., Choi JW; Texas Health Presbyterian Hospital, Dallas, Texas, USA., Poommipanit P; University Hospitals, Case Western Reserve University, Cleveland, USA., Khatri JJ; Cleveland Clinic, Cleveland, Ohio, USA., Alaswad K; Division of Cardiology, Henry Ford Hospital, Detroit, Michigan, USA., Basir MB; Division of Cardiology, Henry Ford Hospital, Detroit, Michigan, USA., Chandwaney RH; Oklahoma Heart Institute, Tulsa, Oklahoma, USA., Gorgulu S; Biruni University Medical School, Istanbul, Turkey., ElGuindy AM; Aswan Heart Center, Magdi Yacoub Foundation, Cairo, Egypt., Elbarouni B; St. Boniface General Hospital, Winnipeg, Manitoba, Canada., Jaber W; Emory University Hospital Midtown, Atlanta, Georgia, USA., Rinfret S; Emory University Hospital Midtown, Atlanta, Georgia, USA., Nicholson W; Emory University Hospital Midtown, Atlanta, Georgia, USA., Jaffer FA; Massachusetts General Hospital, Boston, Massachusetts, USA., Aygul N; Selcuk University, Konya, Turkey., Azzalini L; Division of Cardiology, Department of Medicine, University of Washington, Seattle, Washington, USA., Kearney KE; Division of Cardiology, Department of Medicine, University of Washington, Seattle, Washington, USA., Frizzell J; St. Vincent Hospital, Indianapolis, Indiana, USA., Davies R; WellSpan York Hospital, York, Pennsylvania, USA., Goktekin O; Memorial Bahcelievler Hospital, Istanbul, Turkey., Rangan BV; Minneapolis Heart Institute, Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA., Mastrodemos OC; Minneapolis Heart Institute, Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA., Sandoval Y; Minneapolis Heart Institute, Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA., Nicholas Burke M; Minneapolis Heart Institute, Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA., Brilakis ES; Minneapolis Heart Institute, Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA.
Jazyk: angličtina
Zdroj: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions [Catheter Cardiovasc Interv] 2024 May; Vol. 103 (6), pp. 863-872. Date of Electronic Publication: 2024 Apr 02.
DOI: 10.1002/ccd.31019
Abstrakt: Background: There is limited data on retrograde chronic total occlusion (CTO) percutaneous coronary intervention (PCI) via ipsilateral epicardial collaterals (IEC).
Aims: To compare the clinical and angiographic characteristics, and outcomes of retrograde CTO PCI via IEC versus other collaterals in a large multicenter registry.
Methods: Observational cohort study from the Prospective Global registry for the study of Chronic Total Occlusion Intervention (PROGRESS-CTO).
Results: Of 4466 retrograde cases performed between 2012 and 2023, crossing through IEC was attempted in 191 (4.3%) cases with 50% wiring success. The most common target vessel in the IEC group was the left circumflex (50%), in comparison to other retrograde cases, where the right coronary artery was most common (70%). The Japanese CTO score was similar between the two groups (3.13 ± 1.23 vs. 3.06 ± 1.06, p = 0.456); however, the IEC group had a higher Prospective Global Registry for the Study of Chronic Total Occlusion Intervention (PROGRESS-CTO) score (1.95 ± 1.02 vs. 1.27 ± 0.92, p < 0.0001). The most used IEC guidewire was the SUOH 03 (39%), and the most frequently used microcatheter was the Caravel (43%). Dual injection was less common in IEC cases (66% vs. 89%, p < 0.0001). Technical (76% vs. 79%, p = 0.317) and procedural success rates (74% vs. 79%, p = 0.281) were not different between the two groups. However, IEC cases had a higher procedural complications rate (25.8% vs. 16.4%, p = 0.0008), including perforations (17.3% vs. 9.0%, p = 0.0001), pericardiocentesis (3.1% vs. 1.2%, p = 0.018), and dissection/thrombus of the donor vessel (3.7% vs. 1.2%, p = 0.002).
Conclusion: The use of IEC for retrograde CTO PCI was associated with similar technical and procedural success rates when compared with other retrograde cases, but higher incidence of periprocedural complications.
(© 2024 Wiley Periodicals LLC.)
Databáze: MEDLINE
Externí odkaz: